Oslo February 22, 2021 – Observe Medical ASA (OSE: OBSERV), announces that Nya Karolinska Sjukhuset in Stockholm, Sweden resumes the implementation of Sippi® in clinical use at the Cardiothoracic ICU unit following a pause during 2020, due to Covid-19 As a result of the recent improvements of the Covid-19 situation at the hospital, the…
Oslo February 12, 2021 – Observe Medical ASA (OSE: OBSERV), announces that a major hospital in Northern Italy has equipped the ICU department with Sippi® systems in clinical use, the result of the close collaboration with Observe Medical distributor in Italy, SIM Italia. As a result of the strengthened partnership in 2020 with the distributor…
Oslo February 4, 2021 – Observe Medical ASA (OSE: OBSERV), announces strengthened presence in Norway through a partnership agreement with the Norwegian medtech agency Yallow Life Science AS and an enhanced collaboration with Norway Health Tech. Observe Medical, with headquarters in Oslo, Norway, is launching Sippi® automated digital urine meter in selected markets in Europe.…
Observe Medical ASA, January 15, 2021 – A doctoral (PhD) dissertation at Karolinska Institute, Stockholm, Sweden, demonstrates multiple clinical benefits of the Sippi® automated digital urine meter, and the potential paradigm shift in clinical practice of urine measurement. The PhD thesis ‘Evaluation of an automatic urinometer including use of silicone oil to decrease biofilm formation…
Observe Medical ASA, December 21, 2020: Following the acquisition by Observe Medical of Sylak AB on October 30, the team and product portfolio are now successfully integrated into Observe Medical and in full operations, with focus on the Swedish market. Observe Medical is currently launching Sippi® automated digital urine meter in selected markets in Europe,…
A recently published article demonstrates that the patented Sippcoat® technology, an integrated part of Sippi® system, from Observe Medical, significantly reduces microbial biofilm formation in medical devices, suggesting a new strategy for reducing hospital-acquired infections. The article “Making medical devices safer: impact of plastic and silicone oil on microbial biofilm formation” was recently published in…
Oslo 7 August 2020 – Observe Medical ASA (OSE: OBSERV), today announces it has entered into an updated distribution agreement and strengthened partnership with SIM Italia S.r.l. for the launch of Sippi® in the Italian market. “We are pleased to announce our strengthened partnership with SIM Italia and the signing of an updated distribution agreement…
Oslo, 19 March 2020 – Observe Medical ASA (OSE: OBSERV) today provides a business update in light of COVID-19. The company reports continued high activity level in operations, and several initiatives in the launch and roll-out of Sippi®. “The evolving COVID-19 situation has serious impact on all aspects of the global society, specifically the healthcare…
Observe Medical ASA invites you to a presentation of the fourth quarter and full year 2019 figures. The presentation will take place at Felix Konferansesenter in Oslo on Tuesday, February 25th. Observe Medical – Nya Karolinska Sjukhuset in Sweden resumes the implementation of Sippi® in clinical use at Cardiothoracic ICU unit
Observe Medical – Sippi® installed in clinical use at ICU department at major hospital in Northern Italy
Observe Medical ASA – Strengthened presence in Norway through collaborations with Yallow Life Science AS and Norway Health Tech
Observe Medical ASA – Doctoral dissertation further demonstrates clinical benefits of Sippi®
Observe Medical ASA – Enhanced Nordic sales team in full operations, driving Sippi® clinical use in the Nordics, following the recent acquisition of Sylak AB
Observe Medical: Scientific article provides evidence of Sippi® technology reducing microbial biofilm formation – a risk factor for patient infection
Observe Medical signs updated distribution agreement for Sippi® in Italy
Observe Medical ASA: Business update in light of COVID-19
Observe Medical ASA: Invitation to fourth quarter and full year 2019 presentation